BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16638193)

  • 21. Macrophage Inhibitory Factor-1 (MIF-1) controls the plasticity of multiple myeloma tumor cells.
    Joseph D; Gonsky JP; Blain SW
    PLoS One; 2018; 13(11):e0206368. PubMed ID: 30383785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of genes regulated by 2-methoxyestradiol (2ME2) in multiple myeloma cells using oligonucleotide arrays.
    Chauhan D; Li G; Auclair D; Hideshima T; Richardson P; Podar K; Mitsiades N; Mitsiades C; Li C; Kim RS; Munshi N; Chen LB; Wong W; Anderson KC
    Blood; 2003 May; 101(9):3606-14. PubMed ID: 12480690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunomagnetic enrichment of CD138 positive cells from weakly infiltrated myeloma patients samples enables the determination of the tumor clone specific IgH rearrangement.
    Draube A; Pfister R; Vockerodt M; Schuster S; Kube D; Diehl V; Tesch H
    Ann Hematol; 2001 Feb; 80(2):83-9. PubMed ID: 11261330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
    Kara IO; Sahin B; Paydas S; Cetiner S
    Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tc-99m methoxyisobutylisonitrile bone marrow imaging for predicting the levels of myeloma cells in bone marrow in multiple myeloma: correlation with CD38/CD138 expressing myeloma cells.
    Ak I; Aslan V; Vardareli E; Gülbaş Z
    Ann Hematol; 2003 Feb; 82(2):88-92. PubMed ID: 12601486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential diagnostic power of CD138+ microparticles from the plasma analysis for multiple myeloma clinical monitoring.
    Liu ZY; Tian MY; Deng L; Wang YS; Xing R; Liu H; Fu R
    Hematol Oncol; 2019 Oct; 37(4):401-408. PubMed ID: 31291481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of bone marrow plasma cell infiltrates in multiple myeloma: the added value of CD138 immunohistochemistry.
    Al-Quran SZ; Yang L; Magill JM; Braylan RC; Douglas-Nikitin VK
    Hum Pathol; 2007 Dec; 38(12):1779-87. PubMed ID: 17714757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD138-negative myeloma cells regulate mechanical properties of bone marrow stromal cells through SDF-1/CXCR4/AKT signaling pathway.
    Wu D; Guo X; Su J; Chen R; Berenzon D; Guthold M; Bonin K; Zhao W; Zhou X
    Biochim Biophys Acta; 2015 Feb; 1853(2):338-47. PubMed ID: 25450979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Investigation of the effect of 2-methoxyestradiol and arsenic trioxide on the apoptosis-associated gene expression profile of myeloma cells].
    Xiong H; Hou J; Gao WR; Chen QB
    Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):200-4. PubMed ID: 15949259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apoptosis-resistant phenotype.
    Yaccoby S
    Clin Cancer Res; 2005 Nov; 11(21):7599-606. PubMed ID: 16278377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of CD138 positively selected marrow samples increases the applicability of minimal residual disease assessment by PCR in patients with multiple myeloma.
    Puig N; Sarasquete ME; Alcoceba M; Balanzategui A; Chillón MC; Sebastián E; Marín LA; Díaz MG; San Miguel JF; Sanz RG
    Ann Hematol; 2013 Jan; 92(1):97-100. PubMed ID: 22956183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of low-dose 2-methoxyestradiol on the expressions of two isoforms of PRDM1 gene in myeloma].
    Jiang H; Hou J
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):38-41. PubMed ID: 19563034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between circulating syndecan-1 levels (CD138s) and serum free light chains in monoclonal gammopathies.
    Cigliana G; Torti E; Gulli F; De Santis E; Dell'Abate MT; Colacicco L; Pisani F; Conti L; Basile U
    J Exp Clin Cancer Res; 2015 Apr; 34(1):37. PubMed ID: 26025441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A CD138-independent strategy to detect minimal residual disease and circulating tumour cells in multiple myeloma.
    Muz B; de la Puente P; Azab F; Luderer MJ; King J; Vij R; Azab AK
    Br J Haematol; 2016 Apr; 173(1):70-81. PubMed ID: 26729247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double CD38
    Mykytiv V; Alwaheed A; Mohd Hashim NA
    Hematol Oncol Stem Cell Ther; 2019 Mar; 12(1):64-66. PubMed ID: 29079129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A subpopulation of malignant CD34+CD138+B7-H1+ plasma cells is present in multiple myeloma patients.
    Kuranda K; Berthon C; Dupont C; Wolowiec D; Leleu X; Polakowska R; Jouy N; Quesnel B
    Exp Hematol; 2010 Feb; 38(2):124-31. PubMed ID: 19948206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of an immune-magnetic cell sorting method for CD138-positive plasma cells in FISH analysis of multiple myeloma.
    Shin SY; Jang S; Park CJ; Chi HS; Lee JH; Lee JH; Lee KH; Suh C; Lim SE; Seo EJ
    Int J Lab Hematol; 2012 Oct; 34(5):541-6. PubMed ID: 22672327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells.
    Katodritou E; Terpos E; North J; Kottaridis P; Verrou E; Gastari V; Chadjiaggelidou C; Sivakumaran S; Jide-Banwo S; Tsirogianni M; Kapetanos D; Zervas K; Lowdell MW
    Am J Hematol; 2011 Dec; 86(12):967-73. PubMed ID: 21919039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression and clinical significance of Notch1 on the membrane of bone marrow CD38(+)CD138(+) plasma cells in the patients with multiple myeloma].
    Zhao YR; Fu R; Guan J; Gao S; Liu H; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Wu YH; Song J; Wang HQ; Xing LM; Wang J; Li LJ; Shao ZH
    Zhonghua Xue Ye Xue Za Zhi; 2012 Apr; 33(4):274-7. PubMed ID: 22781716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis.
    Dinner S; Witteles W; Witteles R; Lam A; Arai S; Lafayette R; George TI; Schrier SL; Liedtke M
    Br J Haematol; 2013 May; 161(3):367-72. PubMed ID: 23432783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.